Biotechnology News and Research

RSS

Ingenza’s Ian Fotheringham recognized with prestigious Charles Tennant Memorial Lecture award

Ingenza is proud to announce that Managing Director Ian Fotheringham has been recognized with one of SCI Scotland’s most prestigious honors – the Charles Tennant Memorial Lecture award – acknowledging his expertise and knowledge in chemical research.

16 Jan 2019

Truncal mutations study suggests new direction in origins of cancer

Cancers most commonly arise because of a series of two to five mutations in different genes that combine to cause a tumor.

16 Jan 2019

LifeTime receives fund to develop a plan to embed its vision for healthier future

Our body's cells are constantly changing. But which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a new transnational and interdisciplinary initiative of leading European researchers, aims to discover.

16 Jan 2019

New immune response regulators discovered

The discovery was published in the new iScience journal for interdisciplinary research by Cell Press. The newly discovered regulatory proteins differ significantly from the regulators in mouse immune cells which have been reported earlier. Some of the proteins, such as SATB1 regulating the transcription of several genes, function in the opposite way in human compared to mouse.

16 Jan 2019

Researchers identify a key regulator that stops excessive inflammation

A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.

15 Jan 2019

Bacteria on the International Space Station are adapting to survive, not to harm

Mutant bacteria stranded in space by visiting astronauts have been adapting to survive in their new environment, according to a new study.

10 Jan 2019

Measures of biochemical hypoglycemia linked to high risk of severe hypoglycemic events

Researchers have shown that measures of biochemical hypoglycemia in fingerstick blood samples are associated with an increased risk of severe hypoglycemic events.

10 Jan 2019

NYSCF announce partnership with Ngene to develop new disease treatments

The New York Stem Cell Foundation Research Institute today announced a partnership with Ngene Therapeutics Inc. to develop new disease treatments that leverage human stem cell research and novel gene editing techniques.

10 Jan 2019

Metabolite from berries and pomegranates can mitigate inflammatory bowel disease

Millions of people suffer from inflammatory bowel disease worldwide, either in the form of ulcerative colitis or Crohn's disease, and few effective long-term treatments are available. Chronic intestinal inflammation is a hallmark of IBD.

9 Jan 2019

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

The U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.

9 Jan 2019

Washington University scientists find an unknown route for cellular fuel delivery

Scientists at Washington University School of Medicine in St. Louis have identified a previously unknown route for cellular fuel delivery, a finding that could shed light on the process of aging and the chronic diseases that often accompany it.

8 Jan 2019

Therapeutic implications of caffeine in neuropsychiatric disorders

An important new article reviews recently discovered properties of adenosine A2A receptor-dopamine D2 receptor and adenosine A1 receptor-dopamine D1 receptor heteromers--both of which are main targets for caffeine--and discusses the therapeutic implications of these findings.

7 Jan 2019

Biotechnology News and Research

Ingenza’s Ian Fotheringham recognized with prestigious Charles Tennant Memorial Lecture award

Truncal mutations study suggests new direction in origins of cancer

LifeTime receives fund to develop a plan to embed its vision for healthier future

New immune response regulators discovered

Researchers identify a key regulator that stops excessive inflammation

Bacteria on the International Space Station are adapting to survive, not to harm

Measures of biochemical hypoglycemia linked to high risk of severe hypoglycemic events

NYSCF announce partnership with Ngene to develop new disease treatments

Metabolite from berries and pomegranates can mitigate inflammatory bowel disease

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

Washington University scientists find an unknown route for cellular fuel delivery

Therapeutic implications of caffeine in neuropsychiatric disorders

First viable mouse model of Hirschsprung's disease developed

New report explores the wide-ranging questions on death

Sperm health may play a role in recurrent miscarriages

Study follows children into adolescence to more accurately assess type 1 diabetes risk

Using Assay Kits and Dyes to Advance Cell Biology Research

Varying rules on disposal of organic household rubbish across Europe

Lupin partners with Abbvie to develop and commercialize new targeted oncology treatments

Elegant, low-cost approach enhances single-cell RNA sequencing

Biotechnology eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News